Mentice publishes the company’s year-end report for the period January–December 2019
Encouraging signs for 2020, despite continued lag in the medical device industry in Q4 Fourth quarter 2019 · Net sales amounted to 60.2 (65.2) MSEK. · Operating result for the period before depreciations (EBITDA) totaled 11.8 (24.3) MSEK. · Net result for the period amounted to 7.8 (27.8) MSEK. · Earnings per share (EPS) was 0.32 (2.48) SEK. · Order intake amounted to 54.7 (61.9) MSEK. · The order book was 39.8 (50.1) MSEK. · Cash flow from operating activities totalled -17.4 (12.4) MSEK. January-December 2019 · Net sales amounted to 149.4 (157.0) MSEK.